0001902650-22-000001.txt : 20220107 0001902650-22-000001.hdr.sgml : 20220107 20220107100221 ACCESSION NUMBER: 0001902650-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220107 DATE AS OF CHANGE: 20220107 EFFECTIVENESS DATE: 20220107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trancura Biosciences, Inc. CENTRAL INDEX KEY: 0001902650 IRS NUMBER: 824790867 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-428315 FILM NUMBER: 22516775 BUSINESS ADDRESS: STREET 1: 1555 PARK AVENUE STREET 2: SUITE J CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-225-8366 MAIL ADDRESS: STREET 1: UCSF - QB3 MC 2522 1700 4TH STREET STREET 2: BYERS HALL, SUITE 214 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001902650 Trancura Biosciences, Inc. 1555 PARK AVENUE SUITE J EMERYVILLE CA CALIFORNIA 94608 510-225-8366 DELAWARE None None Corporation true 2018 Francisco Herrera 1555 Park Avenue Suite J Emeryville CA CALIFORNIA 94608 Executive Officer Director President and Chief Executive Officer Pablo D. Valenzuela 1555 Park Avenue Suite J Emeryville CA CALIFORNIA 94608 Director Luis F. Larrondo 1555 Park Avenue Suite J Emeryville CA CALIFORNIA 94608 Executive Officer Secretary Biotechnology Decline to Disclose 06b false 2021-12-23 false true false 0 971666 971666 0 false 3 0 0 0 false Trancura Biosciences, Inc. /s/ Francisco Herrera Francisco Herrera President and Chief Executive Officer 2022-01-07